Drug Product Database record – METHYLENE BLUE INJECTION, DIN 02487993, Phebra Pty Ltd (Canada) (2026)

Government Record · Health Canada, Drug Product Database · November 21, 2026

Health Canada's DPD shows METHYLENE BLUE INJECTION (DIN 02487993, Phebra Pty Ltd) as currently Marketed since 22 September 2020, 10 mg/mL solution for intravenous use, ATC V03AB17.

Current status: Marketed Current status date: 2020-09-22 Original market date: See footnote 1 2020-09-22 Product name: METHYLENE BLUE INJECTION

Health Canada's DPD shows METHYLENE BLUE INJECTION (DIN 02487993, Phebra Pty Ltd) as currently Marketed since 22 September 2020, 10 mg/mL solution for intravenous use, ATC V03AB17. C7 – Canadian record; the holder of the DIN is the Australian company Phebra Pty Ltd, not Provepharm (no Proveblue entry exists in the DPD). Access date 2026-11-21. Additional record fields from the same page: DIN 02487993; company PHEBRA PTY LTD, 19 Orion Road, Lane Cove West, NSW 2066, Australia; class Human; dosage form Solution; route Intravenous; strength METHYLENE BLUE 10 MG / ML; product monograph dated 2019-04-30. A DPD API query for brandname 'methylene blue' returned 11 DINs in total (see the Juno row). Fetch route: curl to health-products.canada.ca DPD HTML plus the /api/drug/status endpoint. Access date 2026-11-21, page undated: the date shown is the date this record page was read; the approval/status dates are the ones quoted from the page. Study type: regulatory record.